Answers are grounded in this paper and cite their sources.
Findings reveal a complex association of LRG1 with insulin resistance and dyslipidemia in obese children, implying metabolic implications.
Findings suggest LRG1 may not serve as a direct biomarker for hepatosteatosis in obese children but is negatively associated with IR and dyslipidemia. These results highlight a complex role for LRG1 in obesity-related metabolic dysfunction and support further longitudinal and pathophysiological studies.
No takes yet. Share an insight, caveat, or question.
Singin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: